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ABSTRACT  
Progressive hearing (pHL) and vestibular (pVL) loss are frequent deficits in Fabry 
disease (FD). Recently, enzyme replacement therapy (ERT) with human -
galactosidase A has become available. Here, we investigate the association between 
pHL and pVL in FD and their ERT responses. Pure tone audiometry (PTA) and head 
impulse testing (HIT) were administered at baseline in 47 patients (25 male, 18-60y; 
22 female, 17-74y), of whom 24 also received caloric irrigation (CI). 38 (24 male) of 
the 47 patients were tested both before and during ERT (follow-up60months). ERT 
consisted of infusions with agalsidase alfa. At baseline, pHL was present in 88% of 
males and 86% of females. Over all tested frequencies (range: 0.5-6kHz), pHL was 
significantly (two-way ANOVA: p<0.05) greater at higher age and in males, with 
largest deficits at high frequencies. When assessed with HIT, 80% of males and 77% 
of females had pVL. pVL was significantly greater at higher age and in males. Tested 
with CI, 21% of males and 0% of females showed vestibular asymmetries. No 
associations among deficits of individual semicircular canal (SCC), as tested by HIT, 
and hearing was observed in individual ears. After 18 months of ERT, pVL was 
significantly smaller than at baseline (ANOVA for HIT: p<0.01). In contrast, pHL 
remained unchanged by ERT over 60 months (p>0.05). We conclude that prevalences 
of pHL and pVL are similar in FD. To detect pVL, HIT is more sensitive than CI. We 
speculate that, pHL and pVL emerge from lesions within the vestibulo-cochlear 
labyrinth, because no specific patterns of vestibulo-cochlear deficits were observed, as 
one would expect if lesions were more proximal along the inferior or superior branch 
of the vestibulo-cochlear nerve or labyrinthine artery. Finally, ERT stabilizes auditory 
function and even improves vestibular function.  
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INTRODUCTION  
In Fabry disease, a X-linked lysosomal storage disorder, deficient activity of the 
enzyme -galactosidase A (-Gal A) [6,22] leads to intracellular accumulation of 
globotriaosylceramide predominantly in the vascular tissue, eye, skin, kidney, heart, 
and nervous system [7,10]. Disease prevalence is estimated between 1:40'000 and 
1:117'000 live births [28]. If later-onset variant phenotypes are included, incidence 
ranges from 1:3100 to 1:4600 [40]. The clinical onset in childhood is characterized by 
painful acroparaesthesias, hypohydrosis, typical angiokeratoma, gastrointestinal 
symptoms, such as abdominal pain and diarrhea, and corneal dystrophy [7,10,27]. 
Renal failure, cardiomyopathy, and cerebrovascular disease cause premature death, on 
average about two decades earlier than in the general population [25-27]. Although 
inheritance is X-chromosomal linked, females can be affected to a mild or severe 
degree due to random X-chromosomal inactivation [43]. Recently enzyme 
replacement therapy (ERT) with recombinant or gene-activated human -Gal A 
provided evidence of reversibility of several clinical manifestations, notably of 
cardial, renal, and peripheral neuropathic symptoms [5,11,19,37,41,44]. 
Hearing loss has often been linked with Fabry disease, but only recent studies have 
ascertained its high prevalence [9,18,27]. Predominantly, hearing loss in Fabry 
disease is of sensorineural type [14,15,18,35]. Likewise, vestibular function seems to 
be commonly affected in Fabry disease, but so far only small case series are available 
[9,30,33]. When cochlear and vestibular impairments in patients with Fabry disease 
are compared, hearing loss is more frequently reported than vestibular loss and an 
independent involvement between the cochlea and the vestibular labyrinth has been 
suggested [9,30]. While studies agree on the prevalence of hearing loss, the 
prevalence of vestibular impairment varies considerably, i.e. ranges from 30 % [9] to 
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50 % [30] when tested with caloric irrigation, and up to 70 % when tested with 
search-coil head impulses [33].  
Caloric irrigation and the search-coil head impulse test are both validated 
assessments of peripheral vestibular function. The advantage of the search-coil head 
impulse test over caloric irrigation consists in a more physiological stimulation of the 
high-frequency range of the vestibular system and the possibility to determine the 
function of individual semicircular canals [3,4,38].  
The present study was prospectively conducted in Fabry patients with the 
following goals: 1) to determine the prevalence of auditory and vestibular 
impairments in male and female patients; 2) to compare vestibular responses as tested 
by head impulses and caloric irrigation; 3) to correlate vestibular function to hearing; 
4) to determine the effect of ERT on vestibular and auditory function.  
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SUBJECTS AND METHODS 
Subjects: Forty-seven patients (25 male, 18-60y, mean 40y; 22 female, 17-74y, 
mean: 34y) diagnosed with Fabry disease (FD) were vestibularly and audiologically 
tested at baseline examination. The diagnosis of FD was confirmed in all patients by 
enzyme assay or DNA analysis. Patients were prospectively recruited from February 
2001 on. Vestibular assessments at baseline included head impulse testing in all 47 
patients, of whom 24 patients (16 male, 18-60y, mean 41y; 8 female, 17-74y, mean: 
44) also received caloric irrigation. Enzyme replacement therapy (ERT) was given to 
38 (24 male) of the 47 patients; for statistical analysis during ERT only data from this 
subgroup were included. All FD patients receiving ERT were tested at relatively 
regular intervals during a period of up to 60 months. ERT consisted of intravenous 
infusions of gene-activated or recombinant human -galactosidase A. Agalsidase alfa 
(Replagal; TKT Europe - SS, Danderyd, Sweden) was given at a dose of 0.2 mg/kg 
every two weeks. The comparison group for vestibular head impulse testing 
comprised 28 healthy subjects (13 male; aged 18-75 years), while normal values for 
audiometric testing were taken from ISO 7029
1
, an internationally accepted age- and 
gender-matched control data. Informed consent was obtained from patients and 
healthy human subjects after a full explanation of the experimental procedure. The 
protocol was approved by a local ethics committee and was in accordance with the 
ethical standards laid down in the 1964 Declaration of Helsinki for research involving 
human subjects.  
                                                 
1
 International Organization for Standardization (2000). Acoustics - Statistical 
distribution of hearing thresholds as a function of age, ISO 7029:2000 
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Auditory testing: Routine pure tone audiometry was performed for auditory 
assessment. The audiometric type, amount, and configuration of hearing loss were 
further analyzed. The type of hearing loss was classified as sensorineural (average air-
bone gap of less than 15 dB for 0.5, 1 and 2 kHz), conductive (normal bone 
conduction thresholds and average air-bone gap of 15 dB or more for 0.5, 1, and 2 
kHz), ore mixed (bone conduction threshold greater than 20 dB HL in combination 
with averaged air-bone gap 15 dB ore more for 0.5, 1, and 2 kHz) according to the 
European Working Group on Genetics and Hearing Impairment
2
. Hearing loss was 
categorized according to pure-tone air conduction thresholds at 0.5, 1, 2, 4, and 6 kHz 
relative to 90
th
 percentiles of the age- and gender-matched ISO 7029 control data. To 
determine the shape of audiometric configurations, we computed the following 
thresholds (T) for each of the two ears in every patient: 
low frequency threshold: T(low) = [T(0.5 kHz) + T(1 kHz)] / 2 
mid frequency threshold: T(mid) = T(2 kHz) 
high frequency threshold: T(high) = [T(4 kHz) + T(6 kHz)] / 2 
Using these three thresholds, audiometric configurations were defined as follows 
(modified definitions from European Working Group on Genetics and Hearing 
Impairment and [9]): 
 flat: T(low) – T(mid)  15 dB HL  AND  T(mid) – T(high)  15 dB HL 
                                                 
2
 http://www.gendeaf.org. Recommendations for description of genetic and 
audiological data for families with nonsyndromic hereditary hearing impairment; 
Composed by the GENDEAF study group on genotype phenotype associations. 
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 mid frequency U-shaped: T(mid) – T(low)  15 dB HL AND T(mid) – 
T(high)  15 dB HL 
 high frequency: T(high) – T(low)  15 dB HL AND T(mid) – T(low) <   
[T(high) – T(low)] / 3 
 sloping: T(high) – T(low)  15 dB HL AND  T(mid) – T(low) >  
[T(high) – T(low)] / 3  
 low frequency: T(low) – T(high)  15 dB HL AND T(mid) – T(high) <  
[T(low) – T(high)] / 3 
 rising: T(low) – T(high)  15 dB HL AND T(mid) – T(high) >  
[T(low) – T(high)] / 3  
Vestibular testing: Caloric irrigation was performed according to the Fitzgerald-
Hallpike testing protocol [13]. In sequence, unilateral 30°C-cold and 44°C-warm 
water irrigation during 20 s with 20 mL of water were performed on either side and 
eye movement responses were video-oculographcally recorded for 180 s [38]. The 
asymmetry of peripheral vestibular function in percent, i.e. the canal paresis factor, 
was determined by Jongkees formula [21]. For quantitative head impulse testing, 
three-dimensional eye and head movements were measured in a magnetic frame 
(Remmel type system, modified by A. Lasker, Baltimore, MA, USA) using dual 
search-coils. Search-coils were calibrated before each session [42]. After 
anaesthetizing the conjunctiva with oxybuprocaine 0.4 %, one search-coil was placed 
on the right eye around the cornea and the other was tightly fixed on the forehead with 
adhesive tape. Voltages were sampled at 16 bits at a frequency of 1000 Hz and stored 
on the hard disk of a computer. During experiments, subjects were seated inside the 
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magnetic coil frame (side length: 1.4 m). Care was taken to position the center of the 
interpupillary line in the centre of the magnetic frame. Rotational head thrusts 
(amplitude: 20-40°; duration: 150-200 ms; peak velocity:  300 °/s; peak acceleration: 
 10000 °/s2) were applied approximately along the planes of the horizontal, left 
anterior and right posterior (LARP), and right anterior and left posterior (RALP) 
semicircular canals by an investigator standing behind the subject. The directions of 
the head impulses were pseudorandomly intermingled and four to six impulses were 
performed in each direction. For each semicircular canal in the appropriate stimulus 
plane, the gain of the vestibulo-ocular reflex (VOR) was determined by computing the 
coefficient ‘eye-in-space displacement divided by head-in-space displacement’ as 
head-in-space moved from 3° to 7° eccentricity from straight-ahead [32]. Note that a 
decreased gain value in the direction of an individual semicircular canal does not 
necessarily imply that the pathology is within this canal; the pathology could as well 
be somewhere along the primary vestibular afferents from this semicircular canal. 
Statistical analysis: To analyze the interference between the patterns of auditory 
and vestibular damage, we used chi-square testing. Wilcoxon rank sum test for equal 
median was performed to determine the effect of age on the high frequency vestibulo-
ocular reflex as tested by head impulses in healthy controls. The effects of age and 
gender on vestibular and audiometric data at baseline data were analyzed with two-
way analysis of variance (ANOVA). Two-way ANOVA was also used to determine 
whether semicircular canals for vestibular function or frequencies for audiometric 
functions were differentially affected by FD. If the outcome of the two-way ANOVA 
was statistically significant, we performed multiple comparisons testing to discern the 
grouping variables that differed significantly. To compare baseline data between 
different groups (e.g. males vs. females), we applied unpaired t-tests. Effects of ERT 
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at different time intervals were evaluated by one-way ANOVA. If the outcome of 
ANOVA testing was statistically significant, we performed multiple comparison 
testing to find out, between which periods of ERT significant differences occurred.  
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RESULTS   
Vestibular and auditory function at baseline 
Figure 1 depicts measures of vestibular (head impulse testing) and auditory (pure 
tone audiography) function in a typical patient with Fabry disease (U. H.; age: 44 
years). For head impulses along the horizontal plane, gains of the vestibulo-ocular 
reflex (VOR) were bilaterally reduced (Fig. 1A), reflecting hypofunction of the 
horizontal semicircular canals (SCC) on both sides. Along the RALP (= right anterior, 
left posterior) plane, VOR gains were reduced for upward head impulses and normal 
for downward head impulses (Fig. 1B), corresponding to reduced left posterior SCC 
and normal right anterior SCC function. VOR gains along the LARP (= left anterior, 
right posterior) plane were reduced in both directions (Fig. 1C), i.e. both left anterior 
SCC and right posterior SCC functions were reduced. In this patient, caloric irrigation 
revealed a normal vestibular function (canal paresis factor: 16 %; data not shown). 
Pure-tone audiometry demonstrated bilateral high-frequency hearing loss with a mean 
high-frequency loss (air conduction at 4 and 6 kHz) of 35 dB for the right and 67.5 dB 
for the left ear (Fig. 1D). However, when these audiometric data were corrected for 
age (ISO 7029, see Methods), the high-frequency hearing loss was restricted to the 
left ear (with 18.5 dB above the mean of the 90
th
 percentiles for 4 and 6 kHz). Thus, 
in this Fabry patient, vestibular deficits were found on both sides, while hearing 
function was impaired on one side only. 
/* FIGURE 1 ABOUT HERE */ 
Figure 2 shows the percentage of male (left bars) and female (right bars) patients 
(N = 47; male = 25) with vestibulo-auditory impairment at baseline examination 
assessed by head impulse testing along different semicircular canal planes (HSCC: 
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horizontal semicircular canals; ASCC: anterior semicircular canals; PSCC: posterior 
semicircular canals), caloric irrigation (CP: canal paresis factor), and pure tone 
audiometry (Audio). Bars indicating the percentage of bilateral (gray area) and 
unilateral (white area) deficits are piled. For example, the horizontal semicircular 
canals (Fig. 2, leftmost bar) were affected bilaterally in 20 % and unilaterally in 48 % 
of male patients. For caloric testing, only the percentage of patients with a 
pathological canal paresis factor - a measure of peripheral vestibular asymmetry (see 
Methods) - is depicted (white area), since no generally accepted parameter for 
bilateral impairment assessed by caloric irrigation is available. Recall that caloric 
irrigation was only performed in 24 patients (16 male), while head impulses and pure 
tone audiometry were completed in all 47 patients.  
/* FIGURE 2 ABOUT HERE */ 
Altogether, in 80 % of male and 77 % of female patients, head impulse tests in at 
least one of six semicircular canal directions were abnormal. Pathological 
asymmetries of caloric responses, i.e. with a canal paresis factor > 25 %, were found 
in 21 % of male and in none of female patients. Thus, vestibular deficits were more 
frequently identified with search-coil head impulse testing than with caloric irrigation. 
In pure tone audiometry, 88 % of male and 86 % of female patients showed impaired 
auditory function compared to age- and gender-matched ISO control data. Hearing 
impairment was sensorineural in all affected patients, i.e. no conductive or mixed 
hearing impairment was observed. Configurations of audiometric thresholds were 
high-frequency in 40 % of males and 9 % of females, flat in 52 % of males and 86 % 
of females, and sloping in 8 % of males and 5 % of females (see Methods for 
definitions). 
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Relation between vestibular and auditory deficits at baseline 
We asked whether there was an association between vestibular and hearing 
impairments in Fabry patients at baseline. Table 1 compares vestibular (as assessed 
with head-impulse testing) and auditory function in the pooled population of male and 
female patients. Clearly, vestibular function did not always parallel auditory function, 
i.e. a vestibular deficit in a patient did not imply a hearing impairment in the same 
patient, and vice versa (chi square: p > 0.05). Likewise, no association between 
vestibular and auditory function was found when analyzing data from male and 
female separately (data not shown).  
/* Table 1 ABOUT HERE */ 
As demonstrated in Table 2, there was not even an association between vestibular 
and auditory function at the level of ipsilateral labyrinths or their afferents. Whether 
or not a Fabry patient had a vestibular deficit on one side (as assessed with head-
impulse testing), was independent of the presence of an auditory deficit on the same 
side, and vice versa (chi square: p > 0.05). Also separate analyses among male and 
female patients found no association between vestibular and auditory function on the 
same side. 
/* Table 2 ABOUT HERE */ 
Figure 3 compares patterns of ipsilateral vestibular and auditory deficits of Fabry 
patients (results from right and left sides are pooled). 32 % of patients showed typical 
patterns of vestibular and auditory deficits that are expected if lesions were situated 
along the branches of the vestibulo-cochlear nerve or labyrinthine artery [12,34]. 
These patterns include (1) horizontal and anterior SCC deficits, (2) posterior SCC and 
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hearing deficits, and (3) deficits of all SCC and hearing. In the majority of patients 
(68 %), however, no pattern was identifiable.  
/* FIGURE 3 ABOUT HERE */ 
Factors determining vestibular and auditory function at baseline and its characteristics 
during ERT 
To statistically analyze the influence of age and gender on vestibular function, we 
first computed the average VOR gain of head impulse testing along the three 
ipsilateral semicircular canals of each ear in every patient. This average VOR gain 
was then normalized by subtracting the grand average of unilateral VOR gains in the 
healthy control group. Since average unilateral VOR gains in our group of healthy 
subjects did not significantly decline with age (Wilcoxon rank sum test for equal 
median p > 0.05), gain values of Fabry patients were not age-corrected. Two-way 
analysis of variance (ANOVA) demonstrated a significant (p < 0.01) influence of age 
and gender on vestibular function in the Fabry patients. Fig. 4A illustrates that 
vestibular function in Fabry patients declines with age, i.e. the duration of the disease, 
and is more reduced in male (squares) than in female (circles) patients.  
 /* FIGURE 4 ABOUT HERE */ 
A similar analysis was performed to investigate the influence of age and gender on 
auditory function. First, differences of pure-tone air conduction thresholds relative to 
the 50 % percentile of age- and gender-matched ISO 7029 control data were 
computed for the five tested frequencies (0.5, 1, 2, 4, 6 kHz). These values were then 
averaged separately for each ear to obtain a unilateral measure of auditory function. 
As for vestibular function, age and gender significantly (two-way ANOVA: p < 0.01) 
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influenced auditory function, with a decline of auditory function with age (or duration 
of disease) and more reduced function in male patients, as shown in Fig. 4B. While all 
semicircular canals in Fabry patients showed similar (p > 0.05) impairment (Fig. 4C), 
auditory deficits were significantly (p < 0.01) different among tested frequencies with 
largest differences at high frequencies (Fig. 4D). 
Figure 5 illustrates the effect of ERT on overall vestibular and auditory function. 
As for Fig. 4, only results from head impulse testing were considered for vestibular 
function. Overall vestibular function of a patient was defined as the average of VOR 
gains obtained by head impulses along the six semicircular canal directions (Fig. 5A). 
Likewise, the overall auditory function of a subject was defined as the average of 
hearing thresholds at 0.5, 1, 2, 4, and 6 kHz of both ears, whereby age- and gender-
correction of hearing thresholds were computed by subtracting the age- and gender-
matched 90
th
 percentiles at each frequency before averaging (Fig. 5B). 
 /* FIGURE 5 ABOUT HERE */ 
Patients were divided into two groups depending on whether the overall VOR gain 
(Fig. 5A) or the overall hearing threshold (Fig. 5B) was within the normal range 
(group_N: triangles) or reduced (group_R: circles) relative to healthy subjects (dashed 
horizontal lines: lower limit). At baseline examination, average overall VOR gains of 
group_R were not significantly different between males and females although overall 
VOR gains of females were less reduced than those of males (average overall gains 
for male 0.59 ± 0.09, for female 0.61 ± 0.08; unpaired t-tests: p > 0.05). In contrast, 
for pure tone audiometry, the average overall hearing thresholds for group_R were 
significantly different between male and female patients with hearing thresholds in 
females less impaired than in males (average overall hearing thresholds for male 47.3 
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dB ± 35.6, for female 21.7 dB ± 10.9; unpaired t-tests: p < 0.05). Overall VOR gains 
and hearing thresholds in group_N were not significantly different between male and 
female patients (unpaired t-tests: p > 0.05).  
Because number of female patients receiving ERT (N = 14) was small, data of 
male and female patients were pooled for further analysis. These data (group_N and 
group_R) were then partitioned according to the time passed from the beginning of 
the ERT to the date of examination (period I: baseline examination, i.e. prior to ERT; 
period II: 1 day – 1.5 year; period III: 1.5 year - 3 years; period IV: 3 years - maximal 
5 years; dashed lines connect average of corresponding groups). For group_N, no 
significant change in both average overall VOR gain (Fig. 5A) and average overall 
hearing threshold (Fig. 5B) was noted during 60 months (ANOVA: p > 0.05). In 
contrast, average overall VOR gain differed significantly among the periods in 
group_R (ANOVA: p < 0.01). Specifically, multiple comparison revealed a 
significant (p < 0.05) vestibular improvement during the first 1.5 year of ERT (Fig. 
5A). Thereafter, overall average VOR gain did not significantly change. 
For auditory function, no significant changes of average hearing thresholds in 
group_R were observed during 60 months, although a slight tendency for further 
deterioration was visible (Fig. 5B). The same analysis as for overall hearing 
thresholds (see Fig. 5B) was repeated for single frequencies (0.5, 1, 2, 4, 6 kHz), 
average high frequency (4 and 6 kHz), and average low frequency (0.5 and 1 kHz). In 
these frequency-specific analyses, we also did not observe any significant changes in 
both group_N and group_R during ERT (data not shown). Finally, since in baseline 
examination, hearing thresholds of female patients differed significantly from male 
patients, all above analyses were repeated for male patients only. Again, no 
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significant changes of auditory function in group_ N and group_R were observed 
during ERT (data not shown).  
In summary, ERT in Fabry patients led to a significant improvement of vestibular 
function, which took place within the first year of treatment, while auditory function 
did not significantly change within the first five years of ERT.  
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DISCUSSION 
Our study confirms the high prevalence of both progressive hearing and vestibular 
loss in patients with Fabry disease and presents detailed analysis on the association 
between auditory and vestibular deficits before and during treatment with enzyme 
replacement therapy (ERT). Sensorineural hearing loss was observed in 88 % of 
males and 86 % of females and comprised all frequency ranges. Hearing loss was 
significantly influenced by age and gender. In particular, auditory function was more 
impaired at higher age and deficits were greater in male than in female patients. 
Additionally, auditory function differed significantly among tested frequencies with 
largest deficits at high frequencies. Vestibular deficits were present in 80 % of males 
and 77 % of females. As in auditory function, vestibular function was significantly 
more impaired in males and at higher age.  
The high prevalence of vestibular deficits in our Fabry patients clearly differs from 
reports of previous studies [9,30]. We believe that our finding is most likely due to the 
higher sensitivity of the search-coil head impulse test in detecting vestibular 
hypofunction compared to caloric irrigation [38]. In fact, only about 21 % of our 
patients showed vestibular abnormalities when assessed by caloric irrigation. This 
relatively low percentage of caloric abnormality agrees with results from the previous 
studies [9,30]. Two factors may explain why patients with Fabry disease show 
vestibular hypofunction more frequently when evaluated with search-coil head 
impulse testing compared to caloric irrigation: (1) The canal paresis factor, which is 
used to quantify caloric irrigation becomes pathological only if vestibular damage is 
asymmetric; in other words, the canal paresis factor is insensitive to roughly bilateral 
vestibular hypofunction. Head impulses, however, show that bilateral vestibular 
damage is not uncommon in Fabry patients (see Fig.2). (2) Typically, the recovery of 
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the vestibulo-ocular reflex (VOR) is frequency-dependent and incomplete at higher 
frequencies and accelerations [29,31,32]. While in patients after vestibular neuritis or 
vestibular neurectomy the low and medium frequency VOR, as assessed by turntable 
testing or caloric irrigation, is centrally compensated within several weeks, the high-
frequency VOR, as assessed by head impulse testing, remains deficient even after 
many years [1-3,8,17,20,23,38,39]. As an additional factor we cannot exclude the 
possibility that high vestibular frequencies are more vulnerable to the pathological 
processes of Fabry disease than low vestibular frequencies. The fact that, in our study, 
all Fabry patients with pathological caloric irrigation had reduced head impulses as 
well and were more than 50 years old might support this hypothesis.  
The location of vestibulo-cochlear damage in Fabry disease is not known. Possible 
sites are the vestibulo-cochlear labyrinth, the eight cranial nerve or the root entry zone 
of the eight cranial nerve. We speculate that the impairment is most likely located 
within the vestibulo-cochlear labyrinth, since we did not observe any specific lesion 
patterns of individual semicircular canals (SCC) and hearing, as one would expect if 
lesions were proximal of the labyrinth along the superior (i.e. concomitant anterior 
SCC and lateral SCC deficits) or the inferior (i.e. concomitant posterior SCC and 
auditory deficit) branch of the vestibular nerve or labyrinthine artery [12,24]. We 
emphasize, however, that with our functional methods, we are not able to determine 
whether neural (including hair cells) or vascular structures within the labyrinth are 
affected in Fabry disease. Histological findings by Schachern et al. in temporal bones 
of two patients with Fabry disease suggest, on the basis of glycosphingolipid 
accumulation in the stria vascularis and in the spiral ganglion cells, that the etiology 
of cochlear lesions at the level of the hair cells is primary of vascular origin [36]. A 
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recent audiometric study by Ries et al. also comes to the conclusion that the auditory 
deficit is due to a cochlear impairment [35]. 
The effect of enzyme replacement therapy (ERT) was analyzed for vestibular and 
auditory function at follow-up examinations over five years. Previous studies in 
patients after vestibular neuritis and neurectomy have shown that unilateral vestibular 
deficits also influence the vestibulo-ocular reflex towards the contralateral healthy 
side by central mechanisms [23,32]. Therefore, to investigate vestibular function 
during ERT, we averaged the vestibulo-ocular responses along the six semicircular 
canals for each patient. For comparison, the same binaural averaging was done for 
auditory function. During ERT over 60 months, auditory function did not significantly 
change in our patients, i.e. there was no indication for recovery, but also no indication 
for deterioration. So far, three other studies have reported on auditory function under 
ERT. While Conti et al. did not see an improvement during the first 12 months [9], 
Hajioff et al. found a significant decrease of sensorineural hearing loss in its high 
frequency range after 18 months [15]. Still Hajioff et al. three years later found in the 
Fabry Outcome Survey a significant decrease of sensorineural hearing loss over all 
frequencies after 12 months [16]. A comparison between our and the other studies 
should only be done with caution because of different analytical methods. Conti et al. 
and the Fabry Outcome Survey study excluded extreme audiometric frequencies when 
calculating the amount of hearing impairment, while Haijoff et al. focused on the high 
frequency hearing impairment and averaged the hearing thresholds at 4 and 8 kHz. 
Our study provides evidence that the overall auditory function (average over all 
hearing thresholds in both ears) as well as the high-frequency auditory function 
(average of hearing thresholds at 4 and 6 kHz in both ears) remains stable during 
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ERT. In sum, to date whether or not auditory function improves under ERT is still not 
conclusively answered.  
In contrast to auditory function, the vestibular function in its high-frequency range 
(assessed by head impulse testing) significantly improved during the first one and a 
half years of ERT and remained unchanged thereafter. In a preliminary study, we 
reported on the effect of ERT on vestibular function as tested by head impulses in a 
much smaller population of Fabry patients. There we found a tendency of vestibular 
recovery within the first 12 months; these results, however, were not statistically 
significant [33]. With about twice the number of Fabry patients in the present study 
the vestibular improvement turned out to be significant. 
In conclusion, we have demonstrated that in patients with Fabry disease vestibular 
deficits occur as frequent as auditory deficits. Functional tests support the hypothesis 
that the vestibular and auditory systems are mainly affected within the labyrinth, 
probably at the level of the hair cells. For the detection of vestibular deficits the 
search-coil head impulse test is more sensitive than caloric irrigation. Finally, ERT 
significantly improves the vestibular function in its high-frequency range, while the 
auditory function is at least stabilized.  
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FIGURE LEGENDS 
Figure 1. Example of head impulses along the horizontal (A), RALP (= right-
anterior & left-posterior semicircular canals) (B) and LARP (= left-anterior & right-
posterior semicircular canals) (C) planes as well as pure tone audiometry (D) in a 
typical patient with Fabry disease (U. H.; age 44 y) at baseline examination. A, B, C: 
If the vestibulo-ocular reflex (VOR) were perfectly compensatory, traces would be 
parallel to the abscissa (head-in-space axis); if the VOR were absent, traces would 
move on a 45° slope. Traces are clipped beyond 10° eccentricity of head-in-space. 
Dashed vertical lines indicate intervals used to determine the gains (see Methods). g: 
median gain value for head impulses. D: Pure tone audiogram. Circles: hearing 
thresholds of the right ear; crosses: hearing thresholds of the left ear. 
Figure 2. Percentages of male (left columns; N = 25) and female (right columns; N 
= 22) patients at baseline examination with unilateral (white area) and bilateral (gray 
area) vestibular and auditory impairments. Horizontal (HSCC), anterior (ASCC), and 
posterior (PSCC) semicircular canal function assessed with search-coil head impulse 
testing. CP: canal paresis factor, i.e. asymmetry of the vestibular function tested by 
caloric testing. Audio: pure tone audiometry (hearing loss relative to ISO). 
Figure 3. Percentages for patterns of impaired semicircular canal (SCC) and 
auditory function within the same ear, as expected by different topographical 
locations of lesions within the labyrinth and its vestibular nerve or blood supply. All: 
impairment of all three SCC and hearing within the same ear; N = 11. HSCC + 
ASCC: deficit of the horizontal and anterior SCC as expected from a lesion along the 
superior branch of the vestibular nerve or labyrinthine artery; N = 9. PSCC + Audio: 
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deficit of the posterior SCC and auditory function as expected from a lesion along the 
inferior branch of the vestibular nerve or labyrinthine artery; N = 10. No pattern: no 
association of the three SCC and auditory function; N = 64.  
Figure 4. Differences of VOR gains obtained by search-coil head impulse testing 
along the three ipsilateral SCC of each ear in every patient normalized to grand 
average of unilateral gains in healthy controls (A, C) and differences of pure-tone air 
conduction thresholds relative to ISO 7029 (B, D) in males (squares) and females 
(circles) at baseline examination. (A) Normalized average VOR gains (error bars: ± 
1SD) plotted at different age intervals; (C) as (A) but plotted for individual SCC. (B) 
Average pure-tone air conduction thresholds relative to 50
th
 percentile of ISO 7029 
(error bars: ± 1SD) plotted at different age intervals; (D) as (B) but plotted for 
individual frequencies. HSCC: horizontal SCC; ASCC: anterior SCC; PSCC: 
posterior SCC. Note that impairment of auditory function was significantly greater at 
higher frequency and at higher age, whereas vestibular function was significantly 
more reduced at higher age, but with no preference for a specific SCC.   
Figure 5. Average of overall VOR gains (error bars: ± 1SD) for search-coil head 
impulses (A) and overall hearing thresholds (error bars: ± 1SD) for pure tone 
audiometry (B) at baseline and during enzyme replacement therapy (I: baseline 
examination, i.e. prior to ERT; II: 1 day – 1.5 year; III: 1.5 year - 3 years; IV: 3 years 
- maximal 5 years). Data from males and females are pooled. Triangles: patients with 
normal values (group_N). Circles: patients with reduced values (group_R). Asterisks: 
significant (p < 0.05) differences of average VOR gains in group_R between periods I 
and II, I and III as well as I and IV. Note that here only patients receiving ERT were 
included in baseline examination (N = 38; males: N = 24).  
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Table 1. Vestibular and auditory deficits in either ear in Fabry patients assessed by 
search-coil head impulse testing and pure tone audiometry.  
Table 2. Right- and left-ear vestibular and auditory deficits in Fabry patients 
assessed by search-coil head impulse testing and pure tone audiometry.  
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